|
1
|
Ammer J, Prantl L, Holler B, Landfried K,
Wolff D, Karrer S, Andreesen R and Holler E: Successful treatment
of a refractory skin ulcer in chronic cutaneous GVHD after
allogeneic HSCT with split-thickness skin allografting from the
stem cell donor. Bone Marrow Transplant. 47:1368–1369. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen X, Chang CH, Stein R and Goldenberg
DM: The humanized anti-HLA-DR moAb, IMMU-114, depletes APCs and
reduces alloreactive T cells: Implications for preventing GVHD.
Bone Marrow Transplant. 47:967–980. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferrara JL, Levine JE, Reddy P and Holler
E: Graft-versus-host disease. Lancet. 373:1550–1561. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lai HY, Chou TY, Tzeng CH and Lee OK:
Cytokine profiles in various graft-versus-host disease target
organs following hematopoietic stem cell transplantation. Cell
Transplant. 21:2033–2045. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ewing MM, Karper JC, Abdul S, de Jong RC,
Peters HA, de Vries MR, Redeker A, Kuiper J, Toes RE, Arens R, et
al: T-cell co-stimulation by CD28-CD80/86 and its negative
regulator CTLA-4 strongly influence accelerated atherosclerosis
development. Int J Cardiol. 168:1965–1974. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cho H and Chung YH: Construction and in
vitro and in vivo analyses of tetravalent immunoadhesins. J
Microbiol Biotechnol. 22:1066–1076. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoo JS, Lee YJ, Yoon JW, Hyung KE and
Hwang KW: CTLA-4-Tg/CD-28-KO mice exhibit reduced T cell
proliferation in vivo compared to CD-28-KO mice in a
graft-versus-host disease model. Korean J Physiol Pharmacol.
16:349–353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu F, Qiao J, Chen W, Pan B, Wu QY, Cao
J, Sang W, Yan ZL, Zeng LY, Li ZY and Xu KL: Increased expression
of T cell immune response cDNA 7 in patients with acute
graft-versus-host disease. Ann Hematol. 94:1025–1032. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumamoto Y, Tomschegg A, Bennai-Sanfourche
F, Boerner A, Kaser A, Schmidt-Knosalla I, Heinemann T, Schlawinsky
M, Blumberg RS, Volk HD and Utku N: Monoclonal antibody specific
for TIRC7 induces donor-specific anergy and prevents rejection of
cardiac allografts in mice. Am J Transplant. 4:505–514. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Utku N, Boerner A, Tomschegg A,
Bennai-Sanfourche F, Bulwin GC, Heinemann T, Loehler J, Blumberg RS
and Volk HD: TIRC7 deficiency causes in vitro and in vivo
augmentation of T and B cell activation and cytokine response. J
Immunol. 173:2342–2352. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kumamoto Y, Tamura A, Volk HD, Reinke P,
Löhler J, Tullius SG and Utku N: TIRC7 is induced in rejected human
kidneys and anti-TIRC7 mAb with FK506 prolongs survival of kidney
allografts in rats. Transpl Immunol. 16:238–244. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu F, Qiao JL, Wu QY, Cao J, Zeng LY, Li
ZY and Xu KL: Elevated levels of T-cell immune response cDNA 7 in
patients with immune thrombocytopenia. Hematology. 19:477–482.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu F, Qiao J, Zhong XM, Wu QY, Chen W,
Yao Y, Niu MS, Fu CL, Zeng LY, Li ZY and Xu KL: Antithymocyte
globulin combined with cyclosporine A down-regulates T helper 1
cells by modulating T-cell immune response cDNA 7 in aplastic
anemia. Med Oncol. 32:1972015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cooke KR, Kobzik L, Martin TR, Brewer J,
Delmonte J Jr, Crawford JM and Ferrara JL: An experimental model of
idiopathic pneumonia syndrome after bone marrow transplantation: I
the roles of minor H antigens and endotoxin. Blood. 88:3230–3239.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Blazar BR, Taylor PA, McElmurry R, Tian L,
Panoskaltsis- Mortari A, Lam S, Lees C, Waldschmidt T and Vallera
DA: Engraftment of severe combined immune deficient mice receiving
allogeneic bone marrow via In utero or postnatal transfer. Blood.
92:3949–3959. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kaplan DH, Anderson BE, McNiff JM, Jain D,
Shlomchik MJ and Shlomchik WD: Target antigens determine
graft-versus-host disease phenotype. J Immunol. 173:5467–5475.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Utku N, Heinemann T, Winter M, Bulwin CG,
Schlawinsky M, Fraser P, Nieuwenhuis EE, Volk HD and Blumberg RS:
Antibody targeting of TIRC7 results in significant therapeutic
effects on collagen-induced arthritis in mice. Clin Exp Immunol.
144:142–151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu F, Zhong XM, Qiao J, Liu Q, Sun HY,
Chen W, Zhao K, Wu QY, Cao J, Sang W, et al: Cytotoxic T lymphocyte
antigen-4 down-regulates T helper 1 cells by increasing expression
of signal transducer and activator of transcription 3 in acute
graft-versus-host disease. Biol Blood Marrow Transplant.
22:212–219. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bulwin GC, Heinemann T, Bugge V, Winter M,
Lohan A, Schlawinsky M, Schulze A, Wälter S, Sabat R, Schülein R,
et al: TIRC7 inhibits T cell proliferation by modulation of CTLA-4
expression. J Immunol. 177:6833–6841. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma HH, Ziegler J, Li C, Sepulveda A,
Bedeir A, Grandis J, Lentzsch S and Mapara MY: Sequential
activation of inflammatory signaling pathways during
graft-versus-host disease (GVHD): Early role for STAT1 and STAT3.
Cell Immunol. 268:37–46. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Betts BC, Sagatys EM, Veerapathran A,
Lloyd MC, Beato F, Lawrence HR, Yue B, Kim J, Sebti SM, Anasetti C
and Pidala J: CD4+ T cell STAT3 phosphorylation precedes acute
GVHD, and subsequent Th17 tissue invasion correlates with GVHD
severity and therapeutic response. J Leukoc Biol. 97:807–819. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Capitini CM, Nasholm NM, Chien CD, Larabee
SM, Qin H, Song YK, Klover PJ, Hennighausen L, Khan J and Fry TJ:
Absence of STAT1 in donor-derived plasmacytoid dendritic cells
results in increased STAT3 and attenuates murine GVHD. Blood.
124:1976–1986. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu Y, Wang D, Liu C, Kaosaard K, Semple K,
Anasetti C and Yu XZ: Prevention of GVHD while sparing GVL effect
by targeting Th1 and Th17 transcription factor T-bet and RORγt in
mice. Blood. 118:5011–5020. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Varkila K and Hurme M: Reduction of acute
graft-versus-host disease-related mortality and cytotoxic T
lymphocyte induction after pretreatment of the recipient with
anti-asialo GM1 antibody in the murine P-to-F1 model. Transplant
Proc. 19:2690–2691. 1987.PubMed/NCBI
|
|
26
|
Krummel MF, Sullivan TJ and Allison JP:
Superantigen responses and co-stimulation: CD28 and CTLA-4 have
opposing effects on T cell expansion in vitro and in vivo. Int
Immunol. 8:519–523. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sarmay G, Koncz G, Pecht I and Gergely J:
Fc gamma receptor type IIb induced recruitment of inositol and
protein phosphatases to the signal transductory complex of human
B-cell. Immunol Lett. 57:159–164. 1997. View Article : Google Scholar : PubMed/NCBI
|
